BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10502747)

  • 1. Can the time from synthesis design to validated chemistry be shortened?
    Pilipauskas DR
    Med Res Rev; 1999 Sep; 19(5):463-74. PubMed ID: 10502747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel synthesis with fluorous reagents and reactants.
    Curran DP
    Med Res Rev; 1999 Sep; 19(5):432-8. PubMed ID: 10502744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Framework for the rapid optimization of soluble protein expression in Escherichia coli combining microscale experiments and statistical experimental design.
    Islam RS; Tisi D; Levy MS; Lye GJ
    Biotechnol Prog; 2007; 23(4):785-93. PubMed ID: 17592858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-oriented and diversity-oriented organic synthesis in drug discovery.
    Schreiber SL
    Science; 2000 Mar; 287(5460):1964-9. PubMed ID: 10720315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured catalysts for organic transformations.
    Chng LL; Erathodiyil N; Ying JY
    Acc Chem Res; 2013 Aug; 46(8):1825-37. PubMed ID: 23350747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of the combination of microwave and parallel synthesis in medicinal chemistry.
    Alcázar J; Dielsb G; Schoentjes B
    Comb Chem High Throughput Screen; 2007 Dec; 10(10):918-32. PubMed ID: 18288951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of micro reactors for organic synthesis.
    Watts P; Haswell SJ
    Chem Soc Rev; 2005 Mar; 34(3):235-46. PubMed ID: 15726160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase-trafficking reagents and phase-switching strategies for parallel synthesis.
    Flynn DL
    Med Res Rev; 1999 Sep; 19(5):408-31. PubMed ID: 10502743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current practices in generation of small molecule new leads.
    Goodnow RA
    J Cell Biochem Suppl; 2001; Suppl 37():13-21. PubMed ID: 11842423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy Effects in the Chemical Synthesis and Extensions of Multicomponent Reactions (MCRs)-The Low Energy Way to Ultra-Short Syntheses of Tailor-Made Molecules.
    Eckert H
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28245622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium- and tellurium-containing fluorescent molecular probes for the detection of biologically important analytes.
    Manjare ST; Kim Y; Churchill DG
    Acc Chem Res; 2014 Oct; 47(10):2985-98. PubMed ID: 25248146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Evolution of DNA-Templated Synthesis as a Tool for Materials Discovery.
    O'Reilly RK; Turberfield AJ; Wilks TR
    Acc Chem Res; 2017 Oct; 50(10):2496-2509. PubMed ID: 28915003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa.
    Dickopf S; Frank M; Junker HD; Maier S; Metz G; Ottleben H; Rau H; Schellhaas N; Schmidt K; Sekul R; Vanier C; Vetter D; Czech J; Lorenz M; Matter H; Schudok M; Schreuder H; Will DW; Nestler HP
    Anal Biochem; 2004 Dec; 335(1):50-7. PubMed ID: 15519570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to high throughput physical organic chemistry.
    Portal C; Bradley M
    Org Biomol Chem; 2007 Feb; 5(4):587-92. PubMed ID: 17285164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.